Keywords
Last Name
Institution

Douglas Dieterich

TitlePROFESSOR
InstitutionMount Sinai
DepartmentLiver Diseases
Address5 East 98th Street
11th Floor
New York NY 10029
Phone212-241-7270
Fax212-241-4465

     Bibliographic 
     selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Martel-Laferrière V, Dieterich DT. Treating HCV in HIV 2013: on the cusp of change. Liver Int. 2014 Feb; 34 Suppl 1:53-9.
      View in: PubMed
    2. Bichoupan K, Schwartz JM, Martel-Laferriere V, Giannattasio ER, Marfo K, Odin JA, Liu LU, Schiano TD, Perumalswami P, Bansal M, Gaglio PJ, Kalia H, Dieterich DT, Branch AD, Reinus JF. Effect of fibrosis on adverse events in patients with hepatitis C treated with telaprevir. Aliment Pharmacol Ther. 2014 Jan; 39(2):209-16.
      View in: PubMed
    3. Shankar H, Bichoupan K, Dieterich DT. The pharmacokinetic evaluation of boceprevir for treatment of Hepatitis C virus. Expert Opin Drug Metab Toxicol. 2013 Nov; 9(12):1647-57.
      View in: PubMed
    4. Branch AD, Drye LT, Van Natta ML, Sezgin E, Fishman SL, Dieterich DT, Meinert CL, Jabs DA. Evaluation of Hepatitis C Virus as a Risk Factor for HIV-Associated Neuroretinal Disorder. Clin Infect Dis. 2013 Dec; 57(11):1618-25.
      View in: PubMed
    5. Han H, Agarwal R, Martel-Laferriere V, Dieterich DT. Antiretroviral and anti-hepatitis C virus direct-acting antiviral-related hepatotoxicity. Clin Liver Dis. 2013 Nov; 17(4):657-70, ix.
      View in: PubMed
    6. Perumalswami PV, Miller FD, Orabee H, Regab A, Adams M, Kapelusznik L, Aljibawi F, Pagano W, Tong V, Dieterich DT. Hepatitis C screening beyond CDC guidelines in an Egyptian immigrant community. Liver Int. 2014 Feb; 34(2):253-8.
      View in: PubMed
    7. Sulkowski MS, Sherman KE, Dieterich DT, Bsharat M, Mahnke L, Rockstroh JK, Gharakhanian S, McCallister S, Henshaw J, Girard PM, Adiwijaya B, Garg V, Rubin RA, Adda N, Soriano V. Combination therapy with telaprevir for chronic hepatitis C virus genotype 1 infection in patients with HIV: a randomized trial. Ann Intern Med. 2013 Jul 16; 159(2):86-96.
      View in: PubMed
    8. Hasham A, Zhang W, Lotay V, Haggerty S, Stefan M, Concepcion E, Dieterich DT, Tomer Y. Genetic analysis of interferon induced thyroiditis (IIT): evidence for a key role for MHC and apoptosis related genes and pathways. J Autoimmun. 2013 Aug; 44:61-70.
      View in: PubMed
    9. Lawitz E, Lalezari JP, Hassanein T, Kowdley KV, Poordad FF, Sheikh AM, Afdhal NH, Bernstein DE, Dejesus E, Freilich B, Nelson DR, Dieterich DT, Jacobson IM, Jensen D, Abrams GA, Darling JM, Rodriguez-Torres M, Reddy KR, Sulkowski MS, Bzowej NH, Hyland RH, Mo H, Lin M, Mader M, Hindes R, Albanis E, Symonds WT, Berrey MM, Muir A. Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial. Lancet Infect Dis. 2013 May; 13(5):401-8.
      View in: PubMed
    10. Burke CC, Martel-Laferriere V, Dieterich DT. Septic bursitis, a potential complication of protease inhibitor use in hepatitis C virus. Clin Infect Dis. 2013 May; 56(10):1507-8.
      View in: PubMed
    11. Martel-Laferrière V, Dieterich DT. Update on combinations of DAAs with and without pegylated-interferon and ribavirin: triple and quadruple therapy more than doubles SVR. Clin Liver Dis. 2013 Feb; 17(1):93-103.
      View in: PubMed
    12. Perumalswami PV, Factor SH, Kapelusznik L, Friedman SL, Pan CQ, Chang C, Di Clemente F, Dieterich DT. Hepatitis Outreach Network: a practical strategy for hepatitis screening with linkage to care in foreign-born communities. J Hepatol. 2013 May; 58(5):890-7.
      View in: PubMed
    13. Fierer DS, Dieterich DT, Fiel MI, Branch AD, Marks KM, Fusco DN, Hsu R, Smith DM, Fierer J. Rapid progression to decompensated cirrhosis, liver transplant, and death in HIV-infected men after primary hepatitis C virus infection. Clin Infect Dis. 2013 Apr; 56(7):1038-43.
      View in: PubMed
    14. Vachon ML, Dieterich DT. A great time to invest in baby Boomer's hepatitis C! Hepatology. 2012 Oct; 56(4):1575-7.
      View in: PubMed
    15. Ladd AM, Martel-Laferriere V, Dieterich D. Successful desensitization to ribavirin in a patient with chronic hepatitis C. J Clin Gastroenterol. 2012 Sep; 46(8):716-7.
      View in: PubMed
    16. Parikh N, Martel-Laferriere V, Zhang X, Dieterich D, Fiel MI, Perumalswami P. Hepatocellular carcinoma in a noncirrhotic patient with HIV: a case report and review of the literature. Semin Liver Dis. 2012 May; 32(2):186-92.
      View in: PubMed
    17. Poordad F, Dieterich D. Treating hepatitis C: current standard of care and emerging direct-acting antiviral agents. J Viral Hepat. 2012 Jul; 19(7):449-64.
      View in: PubMed
    18. Fierer DS, Mullen MP, Dieterich DT, Isabel Fiel M, Branch AD. Early-onset liver fibrosis due to primary hepatitis C virus infection is higher over time in HIV-infected men. Clin Infect Dis. 2012 Sep; 55(6):887-8; author reply 888-9.
      View in: PubMed
    19. Branch AD, Van Natta ML, Vachon ML, Dieterich DT, Meinert CL, Jabs DA. Mortality in hepatitis C virus-infected patients with a diagnosis of AIDS in the era of combination antiretroviral therapy. Clin Infect Dis. 2012 Jul; 55(1):137-44.
      View in: PubMed
    20. Dieterich D. The end of the beginning for hepatitis C treatment. Hepatology. 2012 Mar; 55(3):664-5.
      View in: PubMed
    21. Vachon ML, Dieterich DT. The era of direct-acting antivirals has begun: the beginning of the end for HCV? Semin Liver Dis. 2011 Nov; 31(4):399-409.
      View in: PubMed
    22. Soriano V, Sherman KE, Rockstroh J, Dieterich D, Back D, Sulkowski M, Peters M. Challenges and opportunities for hepatitis C drug development in HIV-hepatitis C virus-co-infected patients. AIDS. 2011 Nov 28; 25(18):2197-208.
      View in: PubMed
    23. Vachon ML, Dieterich DT. The HIV/HCV-coinfected patient and new treatment options. Clin Liver Dis. 2011 Aug; 15(3):585-96.
      View in: PubMed
    24. Weiss JJ, Alcorn MC, Rabkin JG, Dieterich DT. The critical role of medication adherence in the success of boceprevir and telaprevir in clinical practice. J Hepatol. 2012 Feb; 56(2):503-4.
      View in: PubMed
    25. Joshi D, O'Grady J, Dieterich D, Gazzard B, Agarwal K. Increasing burden of liver disease in patients with HIV infection. Lancet. 2011 Apr 2; 377(9772):1198-209.
      View in: PubMed
    26. Schiano TD, Uriel A, Dieterich DT, Fiel MI. The development of hepatoportal sclerosis and portal hypertension due to didanosine use in HIV. Virchows Arch. 2011 Feb; 458(2):231-5.
      View in: PubMed
    27. Vachon ML, Factor SH, Branch AD, Fiel MI, Rodriguez-Torres M, Bräu N, Sterling RK, Slim J, Talal AH, Dieterich DT, Sulkowski MS. Insulin resistance predicts re-treatment failure in an efficacy study of peginterferon-a-2a and ribavirin in HIV/HCV co-infected patients. J Hepatol. 2011 Jan; 54(1):41-7.
      View in: PubMed
    28. Childs KE, Fishman SL, Constable C, Gutierrez JA, Wyatt CM, Dieterich DT, Mullen MP, Branch AD. Short communication: Inadequate vitamin D exacerbates parathyroid hormone elevations in tenofovir users. AIDS Res Hum Retroviruses. 2010 Aug; 26(8):855-9.
      View in: PubMed
    29. Swain MG, Lai MY, Shiffman ML, Cooksley WG, Zeuzem S, Dieterich DT, Abergel A, Pessôa MG, Lin A, Tietz A, Connell EV, Diago M. A sustained virologic response is durable in patients with chronic hepatitis C treated with peginterferon alfa-2a and ribavirin. Gastroenterology. 2010 Nov; 139(5):1593-601.
      View in: PubMed
    30. Rodriguez-Torres M, Torriani F, Rockstroh J, Depamphilis J, Carosi G, Dieterich DT. Degree of viral decline early in treatment predicts sustained virological response in HCV-HIV coinfected patients treated with peginterferon alfa-2a and ribavirin. HIV Clin Trials. 2010 Jan-Feb; 11(1):1-10.
      View in: PubMed
    31. Mikl J, Sulkowski MS, Benhamou Y, Dieterich D, Pol S, Rockstroh J, Robinson PA, Ranga M, Stern JO. Hepatic profile analyses of tipranavir in Phase II and III clinical trials. BMC Infect Dis. 2009; 9:203.
      View in: PubMed
    32. Dieterich DT, Rizzetto M, Manns MP. Management of chronic hepatitis C patients who have relapsed or not responded to pegylated interferon alfa plus ribavirin. J Viral Hepat. 2009 Dec; 16(12):833-43.
      View in: PubMed
    33. Holness G, Carriero DC, Dieterich DT. Hepatitis B therapies and antiviral resistance detection and management. Expert Rev Gastroenterol Hepatol. 2009 Dec; 3(6):693-9.
      View in: PubMed
    34. Fierer DS, Uriel AJ, Carriero DC, Klepper A, Dieterich DT, Mullen MP, Thung SN, Fiel MI, Branch AD. Liver fibrosis during an outbreak of acute hepatitis C virus infection in HIV-infected men: a prospective cohort study. J Infect Dis. 2008 Sep 1; 198(5):683-6.
      View in: PubMed
    35. Keeffe EB, Dieterich DT, Han SH, Jacobson IM, Martin P, Schiff ER, Tobias H. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update. Clin Gastroenterol Hepatol. 2008 Dec; 6(12):1315-41; quiz 1286.
      View in: PubMed
    36. Weiss JJ, Bhatti L, Dieterich DT, Edlin BR, Fishbein DA, Goetz MB, Yu K, Wagner GJ. Hepatitis C patients' self-reported adherence to treatment with pegylated interferon and ribavirin. Aliment Pharmacol Ther. 2008 Aug 1; 28(3):289-93.
      View in: PubMed
    37. Carriero D, Fabrizi F, Uriel AJ, Park J, Martin P, Dieterich DT. Treatment of dialysis patients with chronic hepatitis C using pegylated interferon and low-dose ribavirin. Int J Artif Organs. 2008 Apr; 31(4):295-302.
      View in: PubMed
    38. Keeffe EB, Dieterich DT, Pawlotsky JM, Benhamou Y. Chronic hepatitis B: preventing, detecting, and managing viral resistance. Clin Gastroenterol Hepatol. 2008 Mar; 6(3):268-74.
      View in: PubMed
    39. Rodríguez-Torres M, Govindarajan S, Solá R, Clumeck N, Lissen E, Pessôa M, Buggisch P, Main J, Depamphilis J, Dieterich DT. Hepatic steatosis in HIV/HCV co-infected patients: correlates, efficacy and outcomes of anti-HCV therapy: a paired liver biopsy study. J Hepatol. 2008 May; 48(5):756-64.
      View in: PubMed
    40. Opravil M, Sasadeusz J, Cooper DA, Rockstroh JK, Clumeck N, Clotet B, Montaner J, Torriani FJ, Depamphilis J, Dieterich DT. Effect of baseline CD4 cell count on the efficacy and safety of peginterferon Alfa-2a (40KD) plus ribavirin in patients with HIV/hepatitis C virus coinfection. J Acquir Immune Defic Syndr. 2008 Jan 1; 47(1):36-49.
      View in: PubMed
    41. Rafiq N, Carriero D, Uriel A, Dieterich DT. Treatment of acute hepatitis C in an HIV-positive man with pegylated interferon and ribavirin for 24 weeks. AIDS Read. 2007 Nov; 17(11):561-4.
      View in: PubMed
    42. Huysman A, Patel M, Dieterich DT. Hepatitis B: the immaculate infection. Gastroenterol Hepatol (N Y). 2007 Sep; 3(9):724-6.
      View in: PubMed
    43. Dore GJ, Torriani FJ, Rodriguez-Torres M, Bräu N, Sulkowski M, Lamoglia RS, Tural C, Clumeck N, Nelson MR, Mendes-Correa MC, Godofsky EW, Dieterich DT, Yetzer E, Lissen E, Cooper DA. Baseline factors prognostic of sustained virological response in patients with HIV-hepatitis C virus co-infection. AIDS. 2007 Jul 31; 21(12):1555-9.
      View in: PubMed
    44. Bräu N, Fox RK, Xiao P, Marks K, Naqvi Z, Taylor LE, Trikha A, Sherman M, Sulkowski MS, Dieterich DT, Rigsby MO, Wright TL, Hernandez MD, Jain MK, Khatri GK, Sterling RK, Bonacini M, Martyn CA, Aytaman A, Llovet JM, Brown ST, Bini EJ. Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a U.S.-Canadian multicenter study. J Hepatol. 2007 Oct; 47(4):527-37.
      View in: PubMed
    45. Keeffe EB, Zeuzem S, Koff RS, Dieterich DT, Esteban-Mur R, Gane EJ, Jacobson IM, Lim SG, Naoumov N, Marcellin P, Piratvisuth T, Zoulim F. Report of an international workshop: Roadmap for management of patients receiving oral therapy for chronic hepatitis B. Clin Gastroenterol Hepatol. 2007 Aug; 5(8):890-7.
      View in: PubMed
    46. Dieterich DT. Special considerations and treatment of patients with HBV-HIV coinfection. Antivir Ther. 2007; 12 Suppl 3:H43-51.
      View in: PubMed
    47. Santos SA, Uriel AJ, Park JS, Lucas J, Carriero D, Jaffe D, Dieterich DT. Effect of switching to tenofovir with emtricitabine in patients with chronic hepatitis B failing to respond to an adefovir-containing regimen. Eur J Gastroenterol Hepatol. 2006 Dec; 18(12):1247-53.
      View in: PubMed
    48. Lissen E, Clumeck N, Sola R, Mendes-Correa M, Montaner J, Nelson M, DePamphilis J, Pessôa M, Buggisch P, Main J, Dieterich D. Histological response to pegIFNalpha-2a (40KD) plus ribavirin in HIV-hepatitis C virus co-infection. AIDS. 2006 Nov 14; 20(17):2175-81.
      View in: PubMed
    49. Alvarez D, Dieterich DT, Brau N, Moorehead L, Ball L, Sulkowski MS. Zidovudine use but not weight-based ribavirin dosing impacts anaemia during HCV treatment in HIV-infected persons. J Viral Hepat. 2006 Oct; 13(10):683-9.
      View in: PubMed
    50. Keeffe EB, Dieterich DT, Han SH, Jacobson IM, Martin P, Schiff ER, Tobias H, Wright TL. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update. Clin Gastroenterol Hepatol. 2006 Aug; 4(8):936-62.
      View in: PubMed
    51. Hornberger J, Torriani FJ, Dieterich DT, Bräu N, Sulkowski MS, Torres MR, Green J, Patel K. Cost-effectiveness of peginterferon alfa-2a (40kDa) plus ribavirin in patients with HIV and hepatitis C virus co-infection. J Clin Virol. 2006 Aug; 36(4):283-91.
      View in: PubMed
    52. Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, S Sulkowski M, Torriani FJ, Dieterich DT, Thomas DL, Messinger D, Nelson M. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology. 2006 Jun; 43(6):1317-25.
      View in: PubMed
    53. Kempen JH, Min YI, Freeman WR, Holland GN, Friedberg DN, Dieterich DT, Jabs DA. Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis. Ophthalmology. 2006 Apr; 113(4):684-94.
      View in: PubMed
    54. Patel MR, Mullen MP, Dieterich DT. Sustained virologic response with short-course ribavirin and peginterferon treatment in 2 patients coinfected with HIV and HCV genotype 1. AIDS Read. 2006 Mar; 16(3):164, 168-9; discussion 168-9.
      View in: PubMed
    55. Park JS, Saraf N, Dieterich DT. HBV plus HCV, HCV plus HIV, HBV plus HIV. Curr Gastroenterol Rep. 2006 Feb; 8(1):67-74.
      View in: PubMed
    56. Dieterich DT. Disease management--constructing optimal NRTI-based combinations: past, present, and future. MedGenMed. 2006; 8(1):16.
      View in: PubMed
    57. Dieterich DT. Disease Management - Constructing Optimal NRTI-Based Combinations: Past, Present, and Future. J Int AIDS Soc. 2006; 8(1):16.
      View in: PubMed
    58. Santos SA, Kontorinis N, Dieterich DT. Management of chronic hepatitis C virus in patients with HIV. Curr Treat Options Gastroenterol. 2005 Dec; 8(6):433-41.
      View in: PubMed
    59. Cengiz C, Park JS, Saraf N, Dieterich DT. HIV and liver diseases: recent clinical advances. Clin Liver Dis. 2005 Nov; 9(4):647-66, vii.
      View in: PubMed
    60. Rodriguez-Torres M, Torriani FJ, Soriano V, Borucki MJ, Lissen E, Sulkowski M, Dieterich D, Wang K, Gries JM, Hoggard PG, Back D. Effect of ribavirin on intracellular and plasma pharmacokinetics of nucleoside reverse transcriptase inhibitors in patients with human immunodeficiency virus-hepatitis C virus coinfection: results of a randomized clinical study. Antimicrob Agents Chemother. 2005 Oct; 49(10):3997-4008.
      View in: PubMed
    61. Reichenberg A, Gorman JM, Dieterich DT. Interferon-induced depression and cognitive impairment in hepatitis C virus patients: a 72 week prospective study. AIDS. 2005 Oct; 19 Suppl 3:S174-8.
      View in: PubMed
    62. Kontorinis N, Agarwal K, Dieterich DT. Treatment of hepatitis C virus in HIV patients: a review. AIDS. 2005 Oct; 19 Suppl 3:S166-73.
      View in: PubMed
    63. Sulkowski MS, Dieterich DT, Bini EJ, Bräu N, Alvarez D, Dejesus E, Leitz GJ. Epoetin alfa once weekly improves anemia in HIV/hepatitis C virus-coinfected patients treated with interferon/ribavirin: a randomized controlled trial. J Acquir Immune Defic Syndr. 2005 Aug 1; 39(4):504-6.
      View in: PubMed
    64. Gish RG, Afdhal NH, Dieterich DT, Reddy KR. Management of hepatitis C virus in special populations: patient and treatment considerations. Clin Gastroenterol Hepatol. 2005 Apr; 3(4):311-8.
      View in: PubMed
    65. Carriero DC, Lucas J, Freemantle H, Dieterich DT. The challenge of hepatitis C and HIV co-infection. Body Posit. 2005; 18(1):8-12, 15-7.
      View in: PubMed
    66. Pockros PJ, Shiffman ML, Schiff ER, Sulkowski MS, Younossi Z, Dieterich DT, Wright TL, Mody SH, Tang KL, Goon BL, Bowers PJ, Leitz G, Afdhal NH. Epoetin alfa improves quality of life in anemic HCV-infected patients receiving combination therapy. Hepatology. 2004 Dec; 40(6):1450-8.
      View in: PubMed
    67. Braitstein P, Palepu A, Dieterich D, Benhamou Y, Montaner JS. Special considerations in the initiation and management of antiretroviral therapy in individuals coinfected with HIV and hepatitis C. AIDS. 2004 Nov 19; 18(17):2221-34.
      View in: PubMed
    68. Dieterich DT, Kontorinis N, Agarwal K. HIV/HCV coinfection in clinical practice. J Int Assoc Physicians AIDS Care (Chic). 2004 Oct; 3 Suppl 1:S4-14; quiz S16-7.
      View in: PubMed
    69. Mauss S, Valenti W, DePamphilis J, Duff F, Cupelli L, Passe S, Solsky J, Torriani FJ, Dieterich D, Larrey D. Risk factors for hepatic decompensation in patients with HIV/HCV coinfection and liver cirrhosis during interferon-based therapy. AIDS. 2004 Sep 3; 18(13):F21-5.
      View in: PubMed
    70. Jacobson IM, Ahmed F, Russo MW, Lebovics E, Dieterich DT, Esposito SP, Bach N, Klion F, Tobias H, Antignano L, Brown RS, Gabbaizadeh D, Geders J, Levendoglu H. Interferon alfa-2b [correction of alpha-2b]and ribavirin for patients with chronic hepatitis C and normal ALT. Am J Gastroenterol. 2004 Sep; 99(9):1700-5.
      View in: PubMed
    71. Canchis PW, Yee HT, Fiel MI, Dieterich DT, Liu RC, Chiriboga L, Jacobson IM, Edlin BR, Talal AH. Intrahepatic CD4+ cell depletion in hepatitis C virus/HIV-coinfected patients. J Acquir Immune Defic Syndr. 2004 Sep 1; 37(1):1125-31.
      View in: PubMed
    72. Torriani FJ, Rodriguez-Torres M, Rockstroh JK, Lissen E, Gonzalez-García J, Lazzarin A, Carosi G, Sasadeusz J, Katlama C, Montaner J, Sette H, Passe S, De Pamphilis J, Duff F, Schrenk UM, Dieterich DT. Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. N Engl J Med. 2004 Jul 29; 351(5):438-50.
      View in: PubMed
    73. Chaudhari S, Park J, Anand BS, Pimstone NR, Dieterich DT, Batash S, Bini EJ. Acute pancreatitis associated with interferon and ribavirin therapy in patients with chronic hepatitis C. Dig Dis Sci. 2004 Jun; 49(6):1000-6.
      View in: PubMed
    74. Afdhal NH, Dieterich DT, Pockros PJ, Schiff ER, Shiffman ML, Sulkowski MS, Wright T, Younossi Z, Goon BL, Tang KL, Bowers PJ. Epoetin alfa maintains ribavirin dose in HCV-infected patients: a prospective, double-blind, randomized controlled study. Gastroenterology. 2004 May; 126(5):1302-11.
      View in: PubMed
    75. Volberding PA, Levine AM, Dieterich D, Mildvan D, Mitsuyasu R, Saag M. Anemia in HIV infection: clinical impact and evidence-based management strategies. Clin Infect Dis. 2004 May 15; 38(10):1454-63.
      View in: PubMed
    76. Sulkowski MS, Felizarta F, Smith C, Slim J, Berggren R, Goodman R, Ball L, Khalili M, Dieterich DT. Daily versus thrice-weekly interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected persons: a multicenter randomized controlled trial. J Acquir Immune Defic Syndr. 2004 Apr 15; 35(5):464-72.
      View in: PubMed
    77. Ala A, Dieterich DT. Editorial comment: HIV and HBV coinfection--a coming-of-age in treatment strategies. AIDS Read. 2004 Mar; 14(3):134-5.
      View in: PubMed
    78. Dieterich DT. Hepatitis C infection in HIV. Interview by Vicki Glaser. AIDS Patient Care STDS. 2004 Mar; 18(3):127-30.
      View in: PubMed
    79. Dieterich DT, Robinson PA, Love J, Stern JO. Drug-induced liver injury associated with the use of nonnucleoside reverse-transcriptase inhibitors. Clin Infect Dis. 2004 Mar 1; 38 Suppl 2:S80-9.
      View in: PubMed
    80. Keeffe EB, Dieterich DT, Han SH, Jacobson IM, Martin P, Schiff ER, Tobias H, Wright TL. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States. Clin Gastroenterol Hepatol. 2004 Feb; 2(2):87-106.
      View in: PubMed
    81. Soriano V, Puoti M, Sulkowski M, Mauss S, Cacoub P, Cargnel A, Dieterich D, Hatzakis A, Rockstroh J. Care of patients with hepatitis C and HIV co-infection. AIDS. 2004 Jan 2; 18(1):1-12.
      View in: PubMed
    82. Kontorinis N, Agarwal K, Dieterich DT. Current status of the use of growth factors and other adjuvant medications in patients receiving peginterferon and ribavirin. Rev Gastroenterol Disord. 2004; 4 Suppl 1:S39-47.
      View in: PubMed
    83. Lee W, Dieterich D. Challenges in the management of HIV and hepatitis C virus co-infection. Drugs. 2004; 64(7):693-700.
      View in: PubMed
    84. Dieterich DT, Wasserman R, Bräu N, Hassanein TI, Bini EJ, Bowers PJ, Sulkowski MS. Once-weekly epoetin alfa improves anemia and facilitates maintenance of ribavirin dosing in hepatitis C virus-infected patients receiving ribavirin plus interferon alfa. Am J Gastroenterol. 2003 Nov; 98(11):2491-9.
      View in: PubMed
    85. Dieterich DT. Editorial comment: liver disease in the HIV-infected patient--the courage to treat. AIDS Read. 2003 Oct; 13(10):500-1.
      View in: PubMed
    86. Dieterich D. Managing antiretroviral-associated liver disease. J Acquir Immune Defic Syndr. 2003 Sep; 34 Suppl 1:S34-9.
      View in: PubMed
    87. Dieterich DT, Spivak JL. Hematologic disorders associated with hepatitis C virus infection and their management. Clin Infect Dis. 2003 Aug 15; 37(4):533-41.
      View in: PubMed
    88. Maser E, Dieterich DT. Acute HIV seroconversion in a patient receiving pegylated interferon for treatment of hepatitis C. AIDS Read. 2003 Jun; 13(6):279-80, 287.
      View in: PubMed
    89. Dieterich DT. Human immunodeficiency virus and the liver: lessons learned and still to be learned. Semin Liver Dis. 2003 May; 23(2):107-14.
      View in: PubMed
    90. Kontorinis N, Dieterich DT. Toxicity of non-nucleoside analogue reverse transcriptase inhibitors. Semin Liver Dis. 2003 May; 23(2):173-82.
      View in: PubMed
    91. Dieterich DT. Long-term complications of nucleoside reverse transcriptase inhibitor therapy. AIDS Read. 2003 Apr; 13(4):176-84, 187.
      View in: PubMed
    92. Nerad J, Romeyn M, Silverman E, Allen-Reid J, Dieterich D, Merchant J, A Pelletier V, Tinnerello D, Fenton M. General nutrition management in patients infected with human immunodeficiency virus. Clin Infect Dis. 2003 Apr 1; 36(Suppl 2):S52-62.
      View in: PubMed
    93. Dieterich DT. HIV and hepatitis B virus: options for managing coinfection. Top HIV Med. 2003 Jan-Feb; 11(1):16-9.
      View in: PubMed
    94. Kontorinis N, Dieterich D. Hepatotoxicity of antiretroviral therapy. AIDS Rev. 2003 Jan-Mar; 5(1):36-43.
      View in: PubMed
    95. Dieterich DT. Editorial comment: a tale of two viruses. AIDS Read. 2002 Oct; 12(10):448-9.
      View in: PubMed
    96. Dieterich DT. Treatment of hepatitis C and anemia in human immunodeficiency virus-infected patients. J Infect Dis. 2002 May 15; 185 Suppl 2:S128-37.
      View in: PubMed
    97. Soriano V, Sulkowski M, Bergin C, Hatzakis A, Cacoub P, Katlama C, Cargnel A, Mauss S, Dieterich D, Moreno S, Ferrari C, Poynard T, Rockstroh J. Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV-HCV International Panel. AIDS. 2002 Apr 12; 16(6):813-28.
      View in: PubMed
    98. Palmon R, Koo BC, Shoultz DA, Dieterich DT. Lack of hepatotoxicity associated with nonnucleoside reverse transcriptase inhibitors. J Acquir Immune Defic Syndr. 2002 Apr 1; 29(4):340-5.
      View in: PubMed
    99. Dieterich DT. Hepatitis C management in HIV infection--where is the controversy? AIDS Read. 2002 Jan; 12(1):22-3.
      View in: PubMed
    100. Jones JS, Dieterich DT. Treatment of hepatitis C virus and HIV coinfection: the road less traveled. AIDS Read. 2001 Oct; 11(10):505-10; quiz 529-30.
      View in: PubMed
    101. Talal AH, Weisz K, Hau T, Kreiswirth S, Dieterich DT. A preliminary study of erythropoietin for anemia associated with ribavirin and interferon-alpha. Am J Gastroenterol. 2001 Sep; 96(9):2802-4.
      View in: PubMed
    102. Orenstein JM, Dieterich DT. The histopathology of 103 consecutive colonoscopy biopsies from 82 symptomatic patients with acquired immunodeficiency syndrome: original and look-back diagnoses. Arch Pathol Lab Med. 2001 Aug; 125(8):1042-6.
      View in: PubMed
    103. Talal AH, Irwin CE, Dieterich DT, Yee H, Zhang L. Effect of HIV-1 infection on lymphocyte proliferation in gut-associated lymphoid tissue. J Acquir Immune Defic Syndr. 2001 Mar 1; 26(3):208-17.
      View in: PubMed
    104. Poles MA, Dieterich DT. Infections of the liver in HIV-infected patients. Infect Dis Clin North Am. 2000 Sep; 14(3):741-59.
      View in: PubMed
    105. Poles MA, Dieterich DT. Hepatitis C virus/human immunodeficiency virus coinfection: clinical management issues. Clin Infect Dis. 2000 Jul; 31(1):154-61.
      View in: PubMed
    106. Dieterich DT. Hepatitis C virus and human immunodeficiency virus: clinical issues in coinfection. Am J Med. 1999 Dec 27; 107(6B):79S-84S.
      View in: PubMed
    107. Spaulding AC, Lally M, Rich JD, Dieterich DT. Hepatitis B and C in the context of HIV disease: implications for incarcerated populations. AIDS Read. 1999 Oct; 9(7):481-91.
      View in: PubMed
    108. Abramson SB, Flexner C, Snyderman R, Dieterich DT, Korn D, Temple R, Sherwood L, Goldblatt D. Patients, physicians, and clinical trials: the other side of the coins. J Investig Med. 1999 Sep; 47(8):343-57.
      View in: PubMed
    109. Dieterich DT, Purow JM, Rajapaksa R. Activity of combination therapy with interferon alfa-2b plus ribavirin in chronic hepatitis C patients co-infected with HIV. Semin Liver Dis. 1999; 19 Suppl 1:87-94.
      View in: PubMed
    110. Dieterich DT. Testosterone replacement therapy for HIV-related wasting: abstract and commentary. JAMA. 1998 Dec 9; 280(22):1959-60.
      View in: PubMed
    111. Gambertoglio J, Kumar P, Dieterich D, Jacobson MA. Absence of effect of glutamic acid hydrochloride on the bioavailability of oral ganciclovir in AIDS patients with cytomegalovirus disease. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Aug 1; 18(4):394-6.
      View in: PubMed
    112. Dieterich D. Hepatitis C important treatment advance: interview with Douglas Dieterich, M.D. Interview by John S. James. AIDS Treat News. 1998 May 15; (No 295):1-5.
      View in: PubMed
    113. Whitley RJ, Jacobson MA, Friedberg DN, Holland GN, Jabs DA, Dieterich DT, Hardy WD, Polis MA, Deutsch TA, Feinberg J, Spector SA, Walmsley S, Drew WL, Powderly WG, Griffiths PD, Benson CA, Kessler HA. Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USA. Arch Intern Med. 1998 May 11; 158(9):957-69.
      View in: PubMed
    114. Griffiths RI, Bleecker GC, Jabs DA, Dieterich DT, Coleson L, Winters D, Wolitz R, Steinberg EP. Pharmacoeconomic analysis of 3 treatment strategies for cytomegalovirus retinitis in patients with AIDS. Pharmacoeconomics. 1998 Apr; 13(4):461-74.
      View in: PubMed
    115. Kravetz JD, Lee C, Dieterich DT. Oxandrolone use in Crohn's disease. Am J Gastroenterol. 1997 Dec; 92(12):2330-1.
      View in: PubMed
    116. Dieterich DT, Poles MA, Lew EA, Martin-Munley S, Johnson J, Nix D, Faust MJ. Treatment of gastrointestinal cytomegalovirus infection with twice-daily foscarnet: a pilot study of safety, efficacy, and pharmacokinetics in patients with AIDS. Antimicrob Agents Chemother. 1997 Jun; 41(6):1226-30.
      View in: PubMed
    117. Poles MA, Lew EA, Dieterich DT. Diagnosis and treatment of hepatic disease in patients with HIV. Gastroenterol Clin North Am. 1997 Jun; 26(2):291-321.
      View in: PubMed
    118. Lew EA, Poles MA, Dieterich DT. Diarrheal diseases associated with HIV infection. Gastroenterol Clin North Am. 1997 Jun; 26(2):259-90.
      View in: PubMed
    119. Dieterich DT, Wilcox CM. Diagnosis and treatment of esophageal diseases associated with HIV infection. Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol. 1996 Nov; 91(11):2265-9.
      View in: PubMed
    120. Harren P, Rudow DL, Teperman LW, Dieterich D, Diflo T. Incidence and treatment of recurrent hepatitis C after liver transplantation. J Transpl Coord. 1996 Mar; 6(1):24-7.
      View in: PubMed
    121. Poles MA, Dieterich DT, Schwarz ED, Weinshel EH, Lew EA, Lew R, Scholes JV. Liver biopsy findings in 501 patients infected with human immunodeficiency virus (HIV). J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Feb 1; 11(2):170-7.
      View in: PubMed
    122. Orenstein JM, Lew E, Poles MA, Dieterich D. The endoscopic brush cytology specimen in the diagnosis of intestinal microsporidiosis. AIDS. 1995 Oct; 9(10):1199-201.
      View in: PubMed
    123. Lew E, Dieterich D, Poles M, Scholes J. Gastrointestinal emergencies in the patient with AIDS. Crit Care Clin. 1995 Apr; 11(2):531-60.
      View in: PubMed
    124. Poles MA, McMeeking AA, Scholes JV, Dieterich DT. Actinomyces infection of a cytomegalovirus esophageal ulcer in two patients with acquired immunodeficiency syndrome. Am J Gastroenterol. 1994 Sep; 89(9):1569-72.
      View in: PubMed
    125. Poles MA, Lew EA, Dieterich DT. Predisposition to cytomegalovirus infection of the gastrointestinal tract. Ann Intern Med. 1994 May 1; 120(9):810; author reply 811.
      View in: PubMed
    126. Dieterich DT, Lew EA, Kotler DP, Poles MA, Orenstein JM. Treatment with albendazole for intestinal disease due to Enterocytozoon bieneusi in patients with AIDS. J Infect Dis. 1994 Jan; 169(1):178-83.
      View in: PubMed
    127. Spector SA, Weingeist T, Pollard RB, Dieterich DT, Samo T, Benson CA, Busch DF, Freeman WR, Montague P, Kaplan HJ, et al. A randomized, controlled study of intravenous ganciclovir therapy for cytomegalovirus peripheral retinitis in patients with AIDS. AIDS Clinical Trials Group and Cytomegalovirus Cooperative Study Group. J Infect Dis. 1993 Sep; 168(3):557-63.
      View in: PubMed
    128. Dieterich DT, Poles MA, Lew EA, Mendez PE, Murphy R, Addessi A, Holbrook JT, Naughton K, Friedberg DN. Concurrent use of ganciclovir and foscarnet to treat cytomegalovirus infection in AIDS patients. J Infect Dis. 1993 May; 167(5):1184-8.
      View in: PubMed
    129. Dieterich DT, Poles MA, Dicker M, Tepper R, Lew E. Foscarnet treatment of cytomegalovirus gastrointestinal infections in acquired immunodeficiency syndrome patients who have failed ganciclovir induction. Am J Gastroenterol. 1993 Apr; 88(4):542-8.
      View in: PubMed
    130. Dieterich DT, Kotler DP, Busch DF, Crumpacker C, Du Mond C, Dearmand B, Buhles W. Ganciclovir treatment of cytomegalovirus colitis in AIDS: a randomized, double-blind, placebo-controlled multicenter study. J Infect Dis. 1993 Feb; 167(2):278-82.
      View in: PubMed
    131. Dieterich DT, Lew EA, Bacon DJ, Pearlman KI, Scholes JV. Gastrointestinal pneumocystosis in HIV-infected patients on aerosolized pentamidine: report of five cases and literature review. Am J Gastroenterol. 1992 Dec; 87(12):1763-70.
      View in: PubMed
    132. Orenstein JM, Dieterich DT, Kotler DP. Systemic dissemination by a newly recognized intestinal microsporidia species in AIDS. AIDS. 1992 Oct; 6(10):1143-50.
      View in: PubMed
    133. Lew EA, Dieterich DT. Severe hemorrhage caused by gastrointestinal Kaposi's syndrome in patients with the acquired immunodeficiency syndrome: treatment with endoscopic injection sclerotherapy. Am J Gastroenterol. 1992 Oct; 87(10):1471-4.
      View in: PubMed
    134. Cao YZ, Dieterich D, Thomas PA, Huang YX, Mirabile M, Ho DD. Identification and quantitation of HIV-1 in the liver of patients with AIDS. AIDS. 1992 Jan; 6(1):65-70.
      View in: PubMed
    135. Theise ND, Rotterdam H, Dieterich D. Cytomegalovirus esophagitis in AIDS: diagnosis by endoscopic biopsy. Am J Gastroenterol. 1991 Sep; 86(9):1123-6.
      View in: PubMed
    136. Dieterich DT, Kim MH, McMeeding A, Rotterdam H. Cytomegalovirus appendicitis in a patient with acquired immune deficiency syndrome. Am J Gastroenterol. 1991 Jul; 86(7):904-6.
      View in: PubMed
    137. Dieterich DT, Rahmin M. Cytomegalovirus colitis in AIDS: presentation in 44 patients and a review of the literature. J Acquir Immune Defic Syndr. 1991; 4 Suppl 1:S29-35.
      View in: PubMed
    138. Hochster H, Dieterich D, Bozzette S, Reichman RC, Connor JD, Liebes L, Sonke RL, Spector SA, Valentine F, Pettinelli C, et al. Toxicity of combined ganciclovir and zidovudine for cytomegalovirus disease associated with AIDS. An AIDS Clinical Trials Group Study. Ann Intern Med. 1990 Jul 15; 113(2):111-7.
      View in: PubMed
    139. Cao YZ, Friedman-Kien AE, Mirabile M, Li XL, Alam M, Dieterich D, Ho DD. HIV-1 neutralizing antibodies in urine from seropositive individuals. J Acquir Immune Defic Syndr. 1990; 3(3):195-9.
      View in: PubMed
    140. Dieterich DT, Chachoua A, Lafleur F, Worrell C. Ganciclovir treatment of gastrointestinal infections caused by cytomegalovirus in patients with AIDS. Rev Infect Dis. 1988 Jul-Aug; 10 Suppl 3:S532-7.
      View in: PubMed
    141. Chachoua A, Dieterich D, Krasinski K, Greene J, Laubenstein L, Wernz J, Buhles W, Koretz S. 9-(1,3-Dihydroxy-2-propoxymethyl)guanine (ganciclovir) in the treatment of cytomegalovirus gastrointestinal disease with the acquired immunodeficiency syndrome. Ann Intern Med. 1987 Aug; 107(2):133-7.
      View in: PubMed
    142. Dieterich DT. Cytomegalovirus: a new gastrointestinal pathogen in immunocompromised patients. Am J Gastroenterol. 1987 Aug; 82(8):764-5.
      View in: PubMed
    143. Freedberg RS, Gindea AJ, Dieterich DT, Greene JB. Herpes simplex pericarditis in AIDS. N Y State J Med. 1987 May; 87(5):304-6.
      View in: PubMed
    144. Schaffner AT, Dieterich D. Streetwise narcotic safety. Precautions in home care. Am J Nurs. 1986 Jun; 86(6):707HH-708HH.
      View in: PubMed
    145. Freedman PG, Dieterich DT, Balthazar EJ. Crohn's disease of the esophagus: case report and review of the literature. Am J Gastroenterol. 1984 Nov; 79(11):835-8.
      View in: PubMed
    Dieterich's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts
    _
    Co-Authors
    _
    Similar People
    _
    Same Department
     
    Mount Sinai Profiles is managed by Conduits - The Institutes for Translational Sciences at Icahn School of Medicine, supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number UL1TR000067